the global neuromodulation market is expected to reach $7810.4 million by 2018

Download The global neuromodulation market is expected to reach $7810.4 million by 2018

Post on 06-Apr-2016




0 download

Embed Size (px)


High demand for minimally invasive and noninvasive treatment has fuelled neuromodulation devices market as one of the fastest growing segments of the medical device market today.


  • Email: Tel: +1-888-502-0539

    The global neuromodulation market is expected to reach $7810.4

    million by 2018

    The global neuromodulation market is estimated to be $4503.9 million

    in 2013, and is expected to reach $7810.4 million by 2018 at a CAGR of

    11.6%. Amongst one of the advanced technologies, neuromodulation treats a wide range of chronic and refractory disorders. With

    advancements in technology, neuromodulation is expected to become a

    promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence,

    heart failure, headache, depression, epilepsy, and so on.

    Browse through the market data tables, figures and detailed TOC on the

    Neuromodulation Market.


    The global neuromodulation market comprises two major segments, namely

    internal neurostimulation (deep brain stimulation, spinal cord stimulation,

    vagus nerve stimulation, and sacral nerve stimulation) and external

    neuromodulation (transcranial magnetic stimulation, and transcutaneous

    electrical nerve stimulation (TENS)). Neuromodulation is considered as a

    potential upcoming market segment. The major drivers of this market are

    favorable reimbursement policies, technological advancements, and strong impact of this technology on treating disorders such as Parkinsons, Alzheimers, epilepsy, and sleep apnea.

  • Email: Tel: +1-888-502-0539

    Related Reports

    North American Neuromodulation Market

    The North American neuromodulation market is expected to grow at a CAGR

    of 10.8% from $2740.89 million in 2013 to $4546.21 million in 2018. In the

    next five years primarily due to technical advances and patient-friendly

    techniques such as minimally invasive and non-invasive. The main drivers

    for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimers, epilepsy, spinal cord injury, and Parkinsons disease. According to the U.S. Epilepsy Foundation, about 3 million Americans have suffered from epilepsy until 2012 and about 200,000

    cases of seizures and epilepsy occur each year. According to the U.S.

    Alzheimers Associations, about 5.4 million Americans are expected to suffer from Alzheimers in 2012.The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor, offers the neuromodulation industry opportunities to grow in the

    next five years. The market for treatment of tinnitus, in particular, represents

    an emerging application of neuromodulation.


    European Neuromodulation Market

    The European neuromodulation market is expected to grow at a CAGR of

    12.1% from $1122.06 million in 2013 to $1987.82 million in 2018. Europe is the second largest market, and accounts for a share of 24.8% in 2012.

    Rapidly aging population and higher incidence of chronic disorders will drive

    the European neuromodulation market. According to the European

    Commissions The 2012 Aging Report, there will be a significant increase in the population aged 65 and above by 2060. It was predicted that the

    population will increase twice over from 87.5 million in 2010 to 152.6

    million in 2060 in the European Union, whereas people aged 80 years and

    above is expected to increase from 23.7 million in 2010 to 62.4 million in


  • Email: Tel: +1-888-502-0539

    Asian Neuromodulation Market

    The Asian neuromodulation market is expected to grow at a CAGR of 13.4%

    from $415.32 million in 2013 to $777.62 million in 2018. This region

    contributes 9.1% to the total neuromodulation market (2012). The population is aging at an unprecedented rate, and so are the associated diseases and

    disorders. Some countries are also witnessing a decline in population.

    According to WHO, about 142 million people in the South-East Asia region

    are above the age of 60 years in 2012, and this number is expected to reach

    250 million by 2025. The incidence of dementia is more in the Asian region,

    which accounted for a share of 58% in 2010. This number is expected to rise

    by 71% in 2050. Thus, rise in the aging population in this region will also

    increase the incidence of neurology disorders, and hence the overall market

    for neuromodulation.

    About MicroMarket Monitor

    MicroMarket Monitor identifies and attends to various unmet needs of

    different industrial verticals, which include value chain impact analysis. The

    company publishes about 12000 Market Research Reports on various Micro

    Markets across the world. The graphical nature and multidimensional

    analysis of these reports provide advanced Business Intelligence Tools to the

    clients in that particular target market.


    Mr. Chandrasekhar K.

    5601 Bridge Street

    Suite 300

    Fort Worth

    TX 76112

    Tel: +1-888-502-0539

  • Email: Tel: +1-888-502-0539


    Connect with us on LinkedIn @